Description
Retatrutide 25 mg
Retatrutide (LY-3437U43) is an investigational triple agonist
targeting GLP-1, GIP, and glucagon receptors—designed to enhance weight reduction by combining appetite suppression with increased metabolic activity.
Delivered as a once-weekly prefilled SQ pen (10 mg/1 mL), it’s under study for weight loss, metabolic improvement, and possible anti-aging benefits.
Reviews
There are no reviews yet.